✦ LIBER ✦

High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients

✍ Scribed by C. Lejeune; N. Tubiana; J. A. Gastaut; D. Maraninchi; B. Richard; M. C. Launay; D. Sainty; G. Sebahoun; Y. Carcassonne

Book ID: 114791275
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 417 KB
Volume: 44
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1990.tb00386.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia

✍ Ronald S. Walters; Hagop M. Kantarjian; Michael J. Keating; William K. Plunkett; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Forty-four patients with a diagnosis of refractory or relapsed acute myelogenous leukemia received salvage chemotherapy with high-dose cytosine arabinosine 3 g/m2 intravenously over 2 hours every 12 hours for six doses and mitoxantrone 5 mg/m2 intravenously daily for 5 days. Overall 16 patients (36%

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with high-dose cytosine arabinoside and mitoxantrone in combination

✍ W. Hiddemann; H. Kreutzmann; W.D. Ludwig; H.C. Aul; R. Donhuijsen-Ant; E. Lengfe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

High-dose cytosine arabinoside and mitox

High-dose cytosine arabinoside and mitoxantrone: A highly effective regimen in refractory acute myeloid leukemia

✍ W. Hiddemann; H. Kreutzmann; K. Straif; W. D. Ludwig; R. Donhuijsen-Ant; E. Leng 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Acute polyneuropathy after high dose cyt

Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia

✍ Harry Openshaw; Neal E. Slatkin; Anthony S. Stein; David R. Hinton; Stephen J. F 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

## BACKGROUND. Peripheral nerve toxicity has been reported but is not a commonly recognized complication of high dose cytosine arabinoside (HDAC) therapy. This study was undertaken to estimate the prevalence and describe the clinical spectrum of acute polyneuropathy associated with HDAC therapy fo

High-dose cytosine arabinoside for acute

High-dose cytosine arabinoside for acute nonlymphocytic leukemia

✍ Dr. Guy Cantin; James K. Brennan 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views